Showing results (1791-1800 of 2,084) with videos related to
Sort By:
Pageof 209
NPJ Genomic Medicine|March 28, 2024
Genomic and clinical characterization of a familial GIST kindred intolerant to imatinibK M Ingley, M Zatzman, A M Fontebasso, et al.ESMO Gastrointestinal Oncology|April 17, 2026
Comparative outcomes with low-dose and standard-dose immune checkpoint inhibitors in microsatellite stable advanced gastric/gastroesophageal adenocarcinomaA Ramaswamy, V Shenoy, A Bahl, et al.Blood|January 27, 2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicityChristopher Ronald Funk, Shuhua Wang, Kevin Z Chen, et al.IJTLD Open|October 15, 2025
Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countriesN Suryavanshi, H R Draper, G Dhumal, et al.Eclinicalmedicine|December 31, 2024
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trialAbha A Gupta, Anna Tinker, Derek Jonker, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western IndiaV Mave, S Meshram, R Lokhande, et al.AJNR. American Journal of Neuroradiology|June 15, 2023
Choroid Plexus Calcification Correlates with Cortical Microglial Activation in Humans: A Multimodal PET, CT, MRI StudyT Butler, X H Wang, G C Chiang, et al.Blood Cancer Discovery|November 15, 2021
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom MacroglobulinemiaAkhilesh Kaushal, Ajay K Nooka, Allison R Carr, et al.Injury|May 2, 2019
A checklist for trauma quality improvement meetings: A process improvement studyG M O'Reilly, J Mathew, N Roy, et al.Cancer Research Communications|November 13, 2023
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 InhibitorsDennis Juarez, Roberta Buono, Shannon M Matulis, et al.Pageof 209